z-logo
open-access-imgOpen Access
Antimalarial Activity ofCocos nuciferaHusk Fibre: Further Studies
Author(s) -
Joseph O. Adebayo,
E.A. Balogun,
S. O. Malomo,
Ayodele Olufemi Soladoye,
Lawrence A. Olatunji,
Olatunji Matthew Kolawole,
Olubunmi Stephen Oguntoye,
Abiola Babatunde,
Olugbenga Akinola,
Anna Caroline Campos Aguiar,
Isabel M de Andrade,
Nicolli Bellotti de Souza,
Antoniana U. Krettli
Publication year - 2013
Publication title -
evidence-based complementary and alternative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.552
H-Index - 90
eISSN - 1741-4288
pISSN - 1741-427X
DOI - 10.1155/2013/742476
Subject(s) - cocos nucifera , husk , traditional medicine , botany , biology , medicine
In this study, the antimalarial and toxicity potentials of husk fibre extracts of five Nigerian varieties of Cocos nucifera were evaluated in vitro . The only active extract fraction, West African Tall (WAT) ethyl acetate extract fraction, was then evaluated for its phytochemical constituents, antimalarial and toxicity potentials at varying doses (31.25–500 mg/kg body weight) using various organ function indices. The results revealed that WAT ethyl acetate extract fraction (WATEAEF) contained alkaloids, tannins, and flavonoids and was active against Plasmodium falciparum W2 strain maintained in continuous culture, with a selectivity index of 30.3. The same extract fraction was active in vivo against Plasmodium berghei NK65, causing more than 50% reduction in parasitaemia on days 4 and 6 after inoculation at various doses administered. WATEAEF did not significantly alter ( P > 0.05) function indices of the liver and cardiovascular system at all doses administered but significantly increased ( P < 0.05) plasma creatinine concentration at 250 and 500 mg/Kg body weight compared to controls. The results of this study suggest that WATEAEF possesses antimalarial activity and may not adversely affect normal liver function nor predispose subjects to cardiovascular diseases but may impair normal kidney function at higher doses. Further studies are underway to isolate the active principles.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom